Search
SOLACI Congress
SOLACI Session

Left Atrium Auricle (LLA) closure

solaci
solaci
293
0

This presentation analyzes the feasibility of a program of percutaneous closure of the left atrium auricle (n = 54 p) in patients at high embolism risk and hospital based results – on 30 days. 

Solaci-euroPCR-AD-Damonte
A. Damonte
2012-05-15

Previous article
TAVI registry: Iberoamerica
Next article
CATIS: Immediate reduction in blood pressure demonstrated no benefit in acute stroke
solaci
solaci

More articles by this author

TAVI registry: Iberoamerica

solaci - 0
The objective of this presentation (n = 1248 p, 43 centers in Europe and Latin America) is to evaluate immediate and long-term results of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Session

TAVI registry: Iberoamerica

The objective of this presentation (n = 1248 p, 43 centers in Europe and Latin America) is to evaluate immediate...
solaci -
SOLACI Sessionsspot_img

Recent Articles

Long-Term Predictors of Valve Deterioration After TAVI

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe aortic valve stenosis. Initially implemented in elderly...

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Dr. Juan Manuel Pérez - 0
Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Long-Term Predictors of Valve Deterioration After TAVI

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe aortic valve stenosis. Initially implemented in elderly...

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Dr. Juan Manuel Pérez - 0
Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

Institutional News

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

solaci - 0
The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

solaci - 0
The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

SOLACI Webinar for Nurses and Technicians | Cardiovascular Risk Factors in Women

solaci - 0
Cardiovascular disease remains the leading cause of death in women. Do we truly understand its risk factors and warning signs? 📢 We invite you to...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy